Stereotactic radiosurgical treatment of parenchymal brain metastases from prostate adenocarcinoma

Surgical Neurology

Volumn 69, Issue 6, 2008, Pages 641-646

  Kim, Se Hyuk ^a,b   Chao, Samuel T ^a   Toms, Steven A ^a   Vogelbaum, Michael A ^a   Barnett, Gene H ^a   Suh, John H ^a   Weil, Robert J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Ajou University School of Medicine   (South Korea)

Author keywords

Central nervous system; Gamma Knife; Outcomes; Radiosurgery; Recursive partitioning analysis; Surgery; Tumor

Indexed keywords

ADULT; AGED; AMNESIA; ARTICLE; ATAXIA; BRAIN METASTASIS; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DYSPHASIA; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; HEADACHE; HEMIPARESIS; HUMAN; MALE; OUTCOME ASSESSMENT; PROSTATE CARCINOMA; SEIZURE; STEREOTAXIC SURGERY; TREATMENT OUTCOME; VISUAL FIELD DEFECT;

ADENOCARCINOMA; AGED; BRAIN NEOPLASMS; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIOSURGERY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 43449117479     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2007.05.035     Document Type: Article

References (22)

1. Andrews D.W., Scott C.B., Sperduto P.W., Flanders A.E., Gaspar L.E., Schell M.C., Werner-Wasik M., Demas W., Ryu J., Bahary J.P., Souhami L., Rotman M., Mehta M.P., and Curran Jr. W.J. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363 (2004) 1665-1672
2. Chao S.T., Barnett G.H., Liu S.W., Reuther A.M., Toms S.A., Vogelbaum M.A., Videtic G.M., and Suh J.H. Five-year survivors of brain metastases: a single-institution report of 32 patients. Int J Radiat Oncol Biol Phys 66 (2006) 801-809
3. Fervenza F.C., Wolanskyj A.P., Eklund H.E., and Richardson R.L. Brain metastasis: an unusual complication from prostatic adenocarcinoma. Mayo Clin Proc 75 (2000) 79-82
4. Gaspar L.E., Scott C., Murray K., and Curran W. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47 (2000) 1001-1006
5. Gleason D.F., and Mellinger G.T. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111 (1974) 58-64
6. Hall W.A., Djalilian H.R., Nussbaum E.S., and Cho K.H. Long-term survival with metastatic cancer to the brain. Med Oncol 17 (2000) 279-286
7. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., and Thun M.J. Cancer statistics. CA Cancer J Clin 56 (2006) 106-130
8. Kanner A.A., Suh J.H., Siomin V.E., Lee S.Y., Barnett G.H., and Vogelbaum M.A. Posterior fossa metastases: aggressive treatment improves survival. Stereotact Funct Neurosurg 81 (2003) 18-23
9. McCutcheon I.E., Eng D.Y., and Logothetis C.J. Brain metastasis from prostate carcinoma: antemortem recognition and outcome after treatment. Cancer 86 (1999) 2301-2311
10. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: central nervous system cancers, v.2.2006. Available at:. www.nccn.org [Accessed January 31, 2007]
11. Nelson W.G., De Marzo A.M., and Isaacs W.B. Prostate cancer. N Engl J Med 349 (2003) 366-381
12. Patchell R.A., Tibbs P.A., Walsh J.W., Dempsey R.J., Maruyama Y., Kryscio R.J., Markesbery W.R., Macdonald J.S., and Young B. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322 (1990) 494-500
13. Salvati M., Frati A., Russo N., Brogna C., Piccirilli M., D'Andrea G., Occhiogrosso G., Pichierri A., and Caroli E. Brain metastasis from prostate cancer. Report of 13 cases and critical analysis of the literature. J Exp Clin Cancer Res 24 (2005) 203-207
14. Sanghavi S.N., Miranpuri S.S., Chappell R., Buatti J.M., Sneed P.K., Suh J.H., Regine W.F., Weltman E., King V.J., Goetsch S.J., Breneman J.C., Sperduto P.W., Scott C., Mabanta S., and Mehta M.P. Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 51 (2001) 426-434
15. Singh D., Yi W.S., Brasacchio R.A., Muhs A.G., Smudzin T., Williams J.P., Messing E., and Okunieff P. Is there a favorable subset of patients with prostate cancer who develop oligometastases?. Int J Radiat Oncol Biol Phys 58 (2004) 3-10
16. Sneed P.K., Suh J.H., Goetsch S.J., Sanghavi S.N., Chappell R., Buatti J.M., Regine W.F., Weltman E., King V.J., Breneman J.C., Sperduto P.W., and Mehta M.P. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53 (2002) 519-526
17. Stafinski T., Jhangri G.S., Yan E., and Menon D. Effectiveness of stereotactic radiosurgery alone or in combination with whole brain radiotherapy compared to conventional surgery and/or whole brain radiotherapy for the treatment of one or more brain metastases: a systematic review and meta-analysis. Cancer Treat Rev 32 (2006) 203-213
18. Tendulkar R.D., Liu S.W., Barnett G.H., Vogelbaum M.A., Toms S.A., Jin T., and Suh J.H. RPA classification has prognostic significance for surgically resected single brain metastasis. Int J Radiat Oncol Biol Phys 66 (2006) 810-817
19. Tremont-Lukats I.W., Bobustuc G., Lagos G.K., Lolas K., Kyritsis A.P., and Puduvalli V.K. Brain metastasis from prostate carcinoma: the M. D. Anderson Cancer Center experience. Cancer 98 (2003) 363-368
20. Tsai V., Kim S., Clatterbuck R.E., Ewend M.G., and Olivi A. Cystic prostate metastases to the brain parenchyma: report of two cases and review of the literature. J Neurooncol 51 2 (2001) 167-173
21. Wronski M., Arbit E., Burt M., and Galicich J.H. Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991. J Neurosurg 83 (1995) 605-616
22. Wullich B., Riedinger S., Brinck U., Stoeckle M., Kamradt J., Ketter R., and Jung V. Evidence for gains at 15q and 20q in brain metastases of prostate cancer. Cancer Genet Cytogenet 154 (2004) 119-123